Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Glaxo Consumer Grows 7% Even As JV ‘Moving Parts’ Settle

This article was originally published in The Tan Sheet

Executive Summary

An investor suggests divesting its consumer business and other segments to focus on its Rx and vaccines operations, but CEO Witty says the consumer JV’s early returns point to long-term success. “We see very significant opportunity to create value through the expansion of the margin in consumer,” he says.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS107984

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel